bf/NASDAQ:ORTX_icon.png

COM:ORCHARD-TX

Orchard Therapeutics

  • Stock

USD

Last Close

16.65

23/01 21:00

Market Cap

380.11M

Beta: -

Volume Today

372.35K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
net income
-19.09M
-
-39.74M
108.25%
-230.50M
479.95%
-163.42M
29.10%
-151.98M
7.00%
-144.58M
4.87%
-150.66M
4.20%
depreciation and amortization
6K
-
302K
4,933.33%
1.20M
297.02%
1.68M
39.70%
2.00M
19.64%
2.33M
16.12%
2.74M
17.79%
deferred income tax
-6.30M
-
-6.39M
1.43%
-2.26M
64.68%
1.13M
150.11%
-3.28M
390.27%
stock based compensation
204K
-
1.02M
399.51%
6.77M
563.98%
19.42M
187.08%
27.96M
43.96%
22.54M
19.40%
16.01M
28.96%
change in working capital
1.51M
-
2.81M
86.22%
36.52M
1,199.57%
-17.73M
148.55%
-3.63M
79.54%
-17.06M
370.31%
36.20M
312.18%
accounts receivables
-927K
-
715K
177.13%
582K
18.60%
-624K
207.22%
-7.42M
1,089.10%
inventory
15.72M
-
-10.61M
167.49%
-5.23M
50.72%
-20.11M
284.71%
accounts payables
666K
-
1.93M
189.79%
14.85M
669.33%
-6.41M
143.19%
-1.55M
75.78%
-9.45M
508.63%
13.64M
244.33%
other working capital
843K
-
880K
4.39%
6.88M
681.82%
-1.42M
120.70%
2.57M
280.48%
13.12M
410.58%
29.98M
128.49%
other non cash items
2.80M
-
3.13M
11.64%
94.78M
2,931.86%
311K
99.67%
1.62M
422.19%
10.56M
550%
23.00M
117.90%
net cash provided by operating activities
-14.57M
-
-32.49M
123.03%
-97.54M
200.23%
-166.13M
70.33%
-126.27M
23.99%
-125.10M
0.93%
-75.99M
39.26%
investments in property plant and equipment
-190K
-
-1.56M
720.53%
-4.03M
158.63%
-4.37M
8.31%
-12.67M
190.08%
-3.23M
74.46%
-6.51M
101.36%
acquisitions net
304.99M
-
887K
-
purchases of investments
-414.01M
-
-113.26M
72.64%
-263.88M
132.98%
-112.28M
57.45%
sales maturities of investments
109.02M
-
281.43M
158.15%
234.73M
16.59%
201.39M
14.20%
other investing activites
-304.99M
-
1.88M
100.62%
-671K
135.77%
7.97M
1,287.18%
net cash used for investing activites
-190K
-
-1.56M
720.53%
-4.03M
158.63%
-309.36M
7,572.57%
157.38M
150.87%
-32.16M
120.44%
90.56M
381.55%
debt repayment
-786K
-
common stock issued
205.47M
-
130.27M
36.60%
154.13M
-
common stock repurchased
-392K
-
-19K
95.15%
dividends paid
other financing activites
18.03M
-
115.70M
541.54%
149.40M
29.13%
27.18M
81.80%
3.94M
85.52%
4.32M
9.83%
112K
97.41%
net cash used provided by financing activities
18.03M
-
115.70M
541.54%
354.86M
206.72%
157.45M
55.63%
3.94M
97.50%
158.07M
3,915.90%
-693K
100.44%
effect of forex changes on cash
-751K
-
4.71M
727.03%
-3.47M
173.71%
1.67M
148.17%
1.04M
37.62%
-27K
102.59%
-1.42M
5,155.56%
net change in cash
2.53M
-
86.36M
3,317.45%
249.82M
189.29%
-316.36M
226.63%
36.08M
111.41%
777K
97.85%
12.46M
1,503.73%
cash at beginning of period
970K
-
3.50M
260.52%
89.86M
2,469.52%
339.68M
278.03%
23.32M
93.14%
59.40M
154.75%
60.18M
1.31%
cash at end of period
3.50M
-
89.86M
2,469.52%
339.68M
278.03%
23.32M
93.14%
59.40M
154.75%
60.18M
1.31%
72.64M
20.71%
operating cash flow
-14.57M
-
-32.49M
123.03%
-97.54M
200.23%
-166.13M
70.33%
-126.27M
23.99%
-125.10M
0.93%
-75.99M
39.26%
capital expenditure
-190K
-
-1.56M
720.53%
-4.03M
158.63%
-4.37M
8.31%
-12.67M
190.08%
-3.23M
74.46%
-6.51M
101.36%
free cash flow
-14.76M
-
-34.05M
130.73%
-101.57M
198.33%
-170.50M
67.87%
-138.94M
18.51%
-128.33M
7.64%
-82.50M
35.71%

All numbers in USD (except ratios and percentages)